Ali Elsayed Mohamed Selim, Sebaei Mohamed Abdelfatah, Abdeen Mohamed, Hamada Islam
Zagazig University, Zagazig, Egypt.
Eur J Orthop Surg Traumatol. 2025 Jun 27;35(1):283. doi: 10.1007/s00590-025-04400-7.
This study evaluated the clinical and functional outcomes of minimally invasive anterolateral locked plating for distal tibial fractures.
In this retrospective cohort study, 72 patients with distal tibial fractures (AO/OTA types 43-A, B, and C) were treated between March 2022 and March 2025 using a minimally invasive anterolateral approach with a locked distal tibial plate. Exclusion criteria included open fractures, AO/OTA types 43-B3/C3, polytrauma, and pre-existing limb deformities. Postoperative clinical and radiological outcomes were assessed, and functional outcomes were evaluated using the American Orthopaedic Foot and Ankle Society (AOFAS) score. Functional outcome and complications were recorded over a mean follow-up of 24 months.
The mean age was 45.9 ± 16.6 years; 67% were male, 27% had diabetes, and 22% were smokers. The most common cause of injury was motor vehicle collisions (MVC). Patients included AO 43-A (66.7%), 43-B (22.2%), and 43-C (11.1%) fractures. Most patients maintained an average postoperative range of motion with acceptable alignment. According to AOFAS scores, 72% achieved excellent results, 22% good results (approximately 95% overall satisfaction), and 5% unsatisfactory results. Complications included delayed union (5.6%, predominantly diabetics/smokers), superficial peroneal nerve (SPN) paresthesia (1.4%), and superficial infection (5.6%). Two patients (2.9%) required elective hardware removal.
Minimally invasive anterolateral plating for distal tibial fractures provides reliable fracture stabilization with a high rate of union, acceptable alignment and good functional outcomes making it a favorable treatment option. The approach-specific risk of superficial peroneal nerve neuropraxia, while inherent to anterolateral plating, can be effectively mitigated through meticulous surgical technique, careful identification and protection during exposure.
本研究评估了微创前外侧锁定钢板治疗胫骨干骺端骨折的临床和功能结果。
在这项回顾性队列研究中,2022年3月至2025年3月期间,72例胫骨干骺端骨折(AO/OTA 43-A、B和C型)患者采用微创前外侧入路和胫骨干骺端锁定钢板进行治疗。排除标准包括开放性骨折、AO/OTA 43-B3/C3型骨折、多发伤和既往肢体畸形。评估术后临床和影像学结果,并使用美国矫形足踝协会(AOFAS)评分评估功能结果。在平均24个月的随访期内记录功能结果和并发症。
平均年龄为45.9±16.6岁;67%为男性,27%患有糖尿病,22%为吸烟者。最常见的损伤原因是机动车碰撞(MVC)。患者包括AO 43-A型骨折(66.7%)、43-B型骨折(22.2%)和43-C型骨折(11.1%)。大多数患者术后平均活动范围保持良好,对线可接受。根据AOFAS评分,72%的患者结果优秀,22%的患者结果良好(总体满意度约95%),5%的患者结果不满意。并发症包括骨延迟愈合(5.6%,主要为糖尿病患者/吸烟者)、腓浅神经(SPN)感觉异常(1.4%)和浅表感染(5.6%)。两名患者(2.9%)需要择期取出内固定物。
微创前外侧钢板治疗胫骨干骺端骨折可提供可靠的骨折固定,愈合率高,对线可接受,功能结果良好,是一种理想的治疗选择。腓浅神经神经失用症这一特定入路相关风险虽为前外侧钢板固定所固有,但可通过精细的手术技术、暴露过程中的仔细识别和保护有效减轻。